Hims & Hers Health, Inc. (HIMS) stock
HIMSNYSEServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30191% above fair value
$19.73+0.00 (0.00%)
Close on Nov 13, 2026Market cap $4.60BP/E –Yield –
Hims & Hers Health r&d expenses
Research and development expenses are spending on new products and technology.
No r&d expenses figures for Hims & Hers Health
Hims & Hers Health has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?